Fancl Corp
TSE:4921
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 802
999 999.9999
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Fancl Corp
Net Issuance of Common Stock
Fancl Corp
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fancl Corp
TSE:4921
|
Net Issuance of Common Stock
-¥9m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
|
Shiseido Co Ltd
TSE:4911
|
Net Issuance of Common Stock
-¥1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kao Corp
TSE:4452
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kose Corp
TSE:4922
|
Net Issuance of Common Stock
¥8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fancl Corp
Glance View
In the realm of Japanese innovation, Fancl Corp. stands out as a beacon of progressive beauty and health solutions. Born in 1980, this Yokohama-based company has carved a niche by committing to the principles of purity and simplicity in its products. Fancl's journey began with a bold promise to eliminate preservatives and additives from its skincare and cosmetics line, targeting consumers sensitive to conventional products. This dedication resonates in their flagship offerings, like the preservative-free facial cleansers and nutrient-packed beauty supplements. The company's rigorous approach to product development combines cutting-edge research with a deep understanding of natural ingredients, ensuring high efficacy and safety standards. This unique positioning in the market appeals to the health-conscious demographic, drawing in a loyal customer base that values transparency and innovation. Fancl’s business model thrives on a diversified revenue stream, anchored in both direct-to-consumer and retail strategies. The company adeptly uses a multi-channel distribution system that includes online platforms, brick-and-mortar stores, and strategic partnerships with retailers. It's not just about selling products; Fancl has cultivated a holistic approach that covers direct skincare consultations, personalized health advice, and immersive retail experiences—all reinforcing customer trust and engagement. The seamless integration of these channels not only enhances brand accessibility but also boosts customer retention, driving steady revenue growth. By capitalizing on its reputation for quality and integrity, Fancl continues to expand its footprint both domestically and internationally, navigating the competitive landscape with a keen eye on evolving consumer trends and preferences.
See Also
What is Fancl Corp's Net Issuance of Common Stock?
Net Issuance of Common Stock
-9m
JPY
Based on the financial report for Sep 30, 2024, Fancl Corp's Net Issuance of Common Stock amounts to -9m JPY.
What is Fancl Corp's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
79%
The average annual Net Issuance of Common Stock growth rates for Fancl Corp have been -108% over the past three years , 79% over the past five years .
You don't have any saved screeners yet
